Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
79
-
Total 13F shares, excl. options
-
48.5M
-
Shares change
-
+4.91M
-
Total reported value, excl. options
-
$361M
-
Value change
-
+$36.8M
-
Put/Call ratio
-
0.13
-
Number of buys
-
35
-
Number of sells
-
-29
-
Price
-
$7.45
Significant Holders of LION BIOTECHNOLOGIES INC - COM (LBIO) as of Q1 2017
92 filings reported holding LBIO - LION BIOTECHNOLOGIES INC - COM as of Q1 2017.
LION BIOTECHNOLOGIES INC - COM (LBIO) has 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.5M shares
.
Largest 10 shareholders include BlackRock Inc. (6.07M shares), FRANKLIN RESOURCES INC (5.22M shares), venBio Select Advisor LLC (4.55M shares), FMR LLC (3.84M shares), PERCEPTIVE ADVISORS LLC (3.57M shares), ACUTA CAPITAL PARTNERS, LLC (3.42M shares), ORBIMED ADVISORS LLC (3.38M shares), VICTORY CAPITAL MANAGEMENT INC (2.54M shares), Broadfin Capital, LLC (2.51M shares), and VANGUARD GROUP INC (2.25M shares).
This table shows the top 79 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.